Inceptor Bio

company

About

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$26M
Industries
Biotechnology,Health Care,Wellness
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab and manufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$26M
Inceptor Bio has raised a total of $26M in funding over 2 rounds. Their latest funding was raised on Jun 14, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 14, 2021 Seed $26M 1 Kineticos Disruptor Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Inceptor Bio is funded by 1 investors. Kineticos Disruptor Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Kineticos Disruptor Fund Yes Seed